查詢結果分析
相關文獻
- 鱗狀上皮細胞癌抗原在口腔鱗狀上皮細胞癌患者遠端轉移之分析
- 微型核醣核酸-149基因多型性與罹患口腔鱗狀細胞癌及其預後之相關性
- Prognostic Value of Perineural Invasion and the Quantity of Tumor Involved Nerves in Oral Squamous Cell Carcinoma
- 頰膜鱗狀上皮細胞癌病患術前鱗狀上皮細胞癌抗原--新預後指標?
- Fascin蛋白對口腔鱗狀上皮細胞癌侵襲之臨床意義
- Prognosis of Resecting Local Recurrence for the Cases with Synchronous Distant Metastasis of Rectal Cancer
- The Prognosis of Perineural Invasion in Early Stage Oral Squamous Cell Carcinoma--A Retrospective Study
- 低分化原發性口腔鱗狀上皮細胞癌之預後評估--回顧性研究
- Complicated Urinary Tract Infection: Analysis of 179 Patients
- Prognostic Factors in Node-Negative Breast Cancer Patients: The Experience in Taiwan
頁籤選單縮合
題名 | 鱗狀上皮細胞癌抗原在口腔鱗狀上皮細胞癌患者遠端轉移之分析=Squamous Cell Carcinoma Antigen in Predicting Distant Metastasis in Oral Cavity Squamous Cell Carcinoma |
---|---|
作者 | 楊濟匡; 吳若萱; 廖俊達; 陳一豪; 康仲然; 王毓謙; 黃祥富; Young, Chi-kuang; Wu, Jo-hsuan; Liao, Chun-ta; Chen, I-how; Kang, Chung-jan; Wang, Yu-chien; Huang, Shiang-fu; |
期刊 | 臺灣耳鼻喉頭頸外科雜誌 |
出版日期 | 20140700、20140800、20140900 |
卷期 | 49:3 2014.07-09[民103.07-09] |
頁次 | 頁155-163 |
分類號 | 416.89 |
語文 | chi |
關鍵詞 | 鱗狀上皮細胞癌抗原; 口腔鱗狀上皮細胞癌; 預後; 遠端轉移; Squamous cell carcinoma antigen; Oral squamous cell carcinoma; Prognosis; Distant metastasis; |
中文摘要 | 背景:血液中的鱗狀上皮細胞癌抗原濃度,已經被廣泛應用在許多部位的鱗狀上皮細胞癌上,而且被證實為一有用的腫瘤標誌。先前的文獻已經探討它與口腔鱗狀上皮細胞癌患者臨床病理因子間的關係,然而鱗狀上皮細胞癌抗原對於患者預後及預測遠端轉移的價值仍有待進一步探討。方法:我們以回溯性研究方式追蹤自2008至2011年,共110名口腔鱗狀上皮細胞癌患者(不含口咽 癌與下咽癌的患者),紀錄和進一步分析這些患者的臨床病理因子、手術前和治療後的鱗狀上皮細胞癌抗原濃度。結果:鱗狀上皮細胞癌抗原濃度陽性(≥ 2.0 ng/ml)和腫瘤大小(p < 0.001)、腫瘤病理分期(p = 0.001)、病理淋巴結轉移(p = 0.030)、淋巴結莢膜外侵犯(p = 0.030),無病存活率(p = 0.007)和全存活率(p = 0.016)之間有顯著的相關;且鱗狀上皮細胞癌抗原陽性(≥ 2.0 ng/ml)患者的遠端轉移比率比陰性(< 2.0 ng/ml)患者高(p = 0.019)。結論:此研究顯示,口腔鱗狀上皮細胞癌患者術前血液中的鱗狀上皮細胞癌抗原濃度,可以做為預測病患治療後遠端轉移風險的腫瘤標誌。 |
英文摘要 | Background: Squamous cell carcinoma antigen (SCC-Ag) level was widely used as tumor marker in various human squamous cell carcinomas. It was found to be related to the clinicopathological factors in oral cavity squamous cell carcinoma (OSCC) patients. However, the prognostic value of SCC-Ag and its association with distant metastasis is still uncertain. Methods: We retrospectively analyzed one hundred and ten OSCC patients between 2008 and 2011. The clinicopathologic factors and preoperative and post-treatment serum SCC-Ag levels were recorded. Results: The SCC-Ag level greater than 2.0 ng/ml was significantly associated with the clincopathologic factors including larger tumor size (p < 0.001), advanced pathological stage (p = 0.001), positive pathologic nodes (p = 0.030), extracapsular spreading of the lymph nodes (p = 0.030), shorter disease-free survival (p = 0.007) and overall survival (p = 0.016). The distant metastatic rate is higher in SCC-Ag-positive (≥ 2.0 ng/ml) patients compared to SCC-Ag negative(< 2.0 ng/ml) patients (p = 0.019). Conclusions: The study revealed that preoperative SCC-Ag is a useful marker to identify OSCC patients with risk of distant metastasis. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。